Fortis Healthcare shares are in focus on Friday, November 6, after the company reported its second quarter results. Revenue grew 17.3% to ₹2,734.83 crore, while EBITDA rose 12% to ₹623.19 crore. However, net profit fell 3% to ₹312.38 crore. The hospitals and diagnostics segments showed mixed growth during the period.
Fortis Healthcare's earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 12% to ₹623.19 crore from ₹556.33 crore in the prior fiscal. However, margins saw some contraction from last year.
Shares of Fortis Healthcare Ltd. are in focus on Friday, November 6, after the company reported its second quarter results after market hours on Thursday.
Net profit for the quarter witnessed a 3% decline during the quarter to ₹312.38 crore from ₹321.96 crore last year.
Revenue for Fortis Healthcare stood at ₹2,734.83 crore, a growth of 17.3% from the ₹2,331.44 crore that it reported in the September quarter last year.
Fortis Healthcare's earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 12% to ₹623.19 crore from ₹556.33 crore in the prior fiscal.
EBITDA margins contracted to 22.8% from 23.9% in the year-ago period.
The company's hospitals business' revenue was up 18.6% at ₹2,340 crore in the second quarter from ₹1,974 crore. Profitability for the segment was flat at ₹284 crore from ₹287 crore last year. Its average revenue per patient came in at ₹2.1 lakh compared to ₹1.96 lakh last year, an increase of 7%.
Its occupancy was at 72% compared to 71% in the year-ago period.
Fortis Healthcare's diagnostics business revenue increased 12.2% to ₹448 crore from ₹400 crore in the previous fiscal. Its profit increased by 15.8% to ₹68 crore from ₹59 crore.
Shares of Fortis Healthcare ended the previous session 3.7% higher at ₹819.8 apiece. The stock has gained 7.3% in the past month but is still down 14.3% over the last six months and 9% so far in 2026.